Delivery Order SPE2DB20D1051-SPE2DB25FD8VV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,417.72 on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a $1,345.87 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for completion by July 21, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,726.48 delivery order on July 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with an ultimate completion date of July 21, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, and represents a single delivery order fulfilling federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a delivery order valued at $2,148.90 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract, which is not set-aside and uses firm fixed pricing, is scheduled for completion by July 21, 2025, with performance at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under a larger federal contract vehicle supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $4,753.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a contract ceiling value of $3,903.90. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for ultimate completion by July 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, reflects a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed the delivery order from its corporate office...
- The Defense Logistics Agency awarded a $4,013.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. The contract, which is classified as a child contract with an ultimate completion date of July 21, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD8VVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, which represents no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract delivers a diabetes management pharmaceutical product to support federal healthcare procurement requirements. This delivery order operates under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 total value through December 2026. As a comprehensive global pharmaceutical support vehicle, this prime IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements through competitive, non-set-aside contract mechanisms across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/18/25 |